OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)

BACKGROUND: The first-line treatment for metastatic clear cell renal cell carcinoma (mccRCC) includes immune oncology (IO) based combination therapy. The current standard includes a PD-1 inhibitor plus either an anti-CTLA-4 inhibitor (IO/IO) or an anti-vascular endothelial growth factor receptor tyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckermann, Kathryn, Haake, Scott, Reddy, Anupama, Shyr, Yu, Kimryn Rathmell, W, Pal, Sumanta, Ornstein, Moshe, Barata, Pedro, Zhang, Tian, Rini, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Trials in Progress Abstract Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445578/
http://dx.doi.org/10.1093/oncolo/oyad216.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445578/
http://dx.doi.org/10.1093/oncolo/oyad216.023

Ejemplares similares